Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of AR114935A1publicationCriticalpatent/AR114935A1/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen terapias de combinación que comprenden inhibidores de PD-1 y otros agentes terapéuticos. Las terapias combinadas se pueden usar para tratar o prevenir afecciones y trastornos cancerosos.
ARP180103372A2017-11-162018-11-16Terapias de combinación
AR114935A1
(es)